Quarter Period Consolidated Statement Of Income

Mochida Pharmaceutical Co.,Ltd. - Filing #7537456

Concept 2023-04-01 to
2023-09-30
2022-04-01 to
2022-09-30
Quarter period consolidated statement of income
Statement of income
Net sales
49,476,000,000 JPY
53,200,000,000 JPY
Cost of sales
23,961,000,000 JPY
24,771,000,000 JPY
Gross profit (loss)
25,515,000,000 JPY
28,429,000,000 JPY
Selling, general and administrative expenses
Advertising expenses
2,288,000,000 JPY
1,984,000,000 JPY
Bonuses
1,386,000,000 JPY
1,433,000,000 JPY
Selling, general and administrative expenses
21,563,000,000 JPY
23,149,000,000 JPY
Operating profit (loss)
3,952,000,000 JPY
5,279,000,000 JPY
Non-operating income
Interest income
1,000,000 JPY
1,000,000 JPY
Dividend income
181,000,000 JPY
171,000,000 JPY
Non-operating income
253,000,000 JPY
229,000,000 JPY
Non-operating expenses
Interest expenses
0 JPY
JPY
Share of loss of entities accounted for using equity method
115,000,000 JPY
JPY
Non-operating expenses
152,000,000 JPY
66,000,000 JPY
Ordinary profit (loss)
4,053,000,000 JPY
5,443,000,000 JPY
Extraordinary income
Extraordinary income
27,000,000 JPY
10,000,000 JPY
Extraordinary losses
Extraordinary losses
31,000,000 JPY
41,000,000 JPY
Profit (loss) before income taxes
4,049,000,000 JPY
5,412,000,000 JPY
Income taxes
1,210,000,000 JPY
1,489,000,000 JPY
Profit (loss)
2,838,000,000 JPY
3,923,000,000 JPY
Profit attributable to
Profit (loss) attributable to owners of parent
2,838,000,000 JPY
3,923,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
2,105,000,000 JPY
-511,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-22,000,000 JPY
-21,000,000 JPY
Other comprehensive income
2,082,000,000 JPY
-533,000,000 JPY
Comprehensive income
4,921,000,000 JPY
3,389,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
4,921,000,000 JPY
3,389,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.